THE US-ISRAEL - Legal Review 2026

131 should be viewed as part of a firm’s risk management system rather than as a personal productivity choice. A sensible policy includes: (i) a default prohibition on uploading client-confidential invention substance into consumer AI tools; (ii) an approved list of enterprise tools with clear contractual terms, data-segregation commitments, and training opt-outs; (iii) redaction protocols and “minimum necessary disclosure” guidelines; and (iv) periodic training so that engineers and attorneys understand that “asking AI for help” can be the functional equivalent of disclosing to an uncontrolled audience. The practical aim is simple: preserve a credible narrative. In later proceedings, the patentee should be able to show a dated human-authored disclosure, a filing strategy aligned with global novelty rules, and an AI-use record that did not create uncontrolled dissemination. That narrative will often be more valuable than any short-term drafting convenience. ISRAEL — INTELLECTUAL PROPERTY

RkJQdWJsaXNoZXIy MjgzNzA=